| UniProt ID | PTN9_HUMAN | |
|---|---|---|
| UniProt AC | P43378 | |
| Protein Name | Tyrosine-protein phosphatase non-receptor type 9 | |
| Gene Name | PTPN9 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 593 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | Protein-tyrosine phosphatase that could participate in the transfer of hydrophobic ligands or in functions of the Golgi apparatus.. | |
| Protein Sequence | MEPATAPRPDMAPELTPEEEQATKQFLEEINKWTVQYNVSPLSWNVAVKFLMARKFDVLRAIELFHSYRETRRKEGIVKLKPHEEPLRSEILSGKFTILNVRDPTGASIALFTARLHHPHKSVQHVVLQALFYLLDRAVDSFETQRNGLVFIYDMCGSNYANFELDLGKKVLNLLKGAFPARLKKVLIVGAPIWFRVPYSIISLLLKDKVRERIQILKTSEVTQHLPRECLPENLGGYVKIDLATWNFQFLPQVNGHPDPFDEIILFSLPPALDWDSVHVPGPHAMTIQELVDYVNARQKQGIYEEYEDIRRENPVGTFHCSMSPGNLEKNRYGDVPCLDQTRVKLTKRSGHTQTDYINASFMDGYKQKNAYIGTQGPLENTYRDFWLMVWEQKVLVIVMTTRFEEGGRRKCGQYWPLEKDSRIRFGFLTVTNLGVENMNHYKKTTLEIHNTEERQKRQVTHFQFLSWPDYGVPSSAASLIDFLRVVRNQQSLAVSNMGARSKGQCPEPPIVVHCSAGIGRTGTFCSLDICLAQLEELGTLNVFQTVSRMRTQRAFSIQTPEQYYFCYKAILEFAEKEGMVSSGQNLLAVESQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEPATAPR -------CCCCCCCC | 14.54 | 19413330 | |
| 67 | Phosphorylation | RAIELFHSYRETRRK HHHHHHHHHHHHHCC | 20.67 | 30206219 | |
| 68 | Phosphorylation | AIELFHSYRETRRKE HHHHHHHHHHHHCCC | 12.14 | 30206219 | |
| 71 | Phosphorylation | LFHSYRETRRKEGIV HHHHHHHHHCCCCCE | 27.12 | 30206219 | |
| 79 | Ubiquitination | RRKEGIVKLKPHEEP HCCCCCEECCCCCCC | 49.20 | - | |
| 89 | Phosphorylation | PHEEPLRSEILSGKF CCCCCCHHHHHCCCE | 36.35 | 20068231 | |
| 93 | Phosphorylation | PLRSEILSGKFTILN CCHHHHHCCCEEEEE | 45.67 | 20068231 | |
| 97 | Phosphorylation | EILSGKFTILNVRDP HHHCCCEEEEEECCC | 28.21 | 20068231 | |
| 133 | Phosphorylation | VVLQALFYLLDRAVD HHHHHHHHHHHHHHH | 13.75 | - | |
| 141 | Phosphorylation | LLDRAVDSFETQRNG HHHHHHHCHHHHHCC | 20.55 | 27251275 | |
| 144 | Phosphorylation | RAVDSFETQRNGLVF HHHHCHHHHHCCEEE | 30.71 | 27251275 | |
| 153 | Phosphorylation | RNGLVFIYDMCGSNY HCCEEEEEECCCCCC | 6.02 | 27251275 | |
| 158 | Phosphorylation | FIYDMCGSNYANFEL EEEECCCCCCCEEEE | 23.03 | 27251275 | |
| 160 | Phosphorylation | YDMCGSNYANFELDL EECCCCCCCEEEEHH | 12.48 | 27251275 | |
| 170 | Ubiquitination | FELDLGKKVLNLLKG EEEHHHHHHHHHHCC | 50.59 | - | |
| 176 | Ubiquitination | KKVLNLLKGAFPARL HHHHHHHCCCCCHHH | 51.89 | - | |
| 185 | Ubiquitination | AFPARLKKVLIVGAP CCCHHHCEEEEECCC | 47.03 | 21890473 | |
| 218 | Ubiquitination | RERIQILKTSEVTQH HHHHHHHCCCHHHHC | 52.19 | - | |
| 300 | Ubiquitination | DYVNARQKQGIYEEY HHHHHHHHCCCCHHH | 44.96 | - | |
| 304 | Phosphorylation | ARQKQGIYEEYEDIR HHHHCCCCHHHHHHH | 14.99 | 28796482 | |
| 307 | Phosphorylation | KQGIYEEYEDIRREN HCCCCHHHHHHHHHC | 13.63 | 28796482 | |
| 318 | Phosphorylation | RRENPVGTFHCSMSP HHHCCCEEEECCCCC | 15.50 | 22199227 | |
| 322 | Phosphorylation | PVGTFHCSMSPGNLE CCEEEECCCCCCCCC | 17.45 | 25159151 | |
| 324 | Phosphorylation | GTFHCSMSPGNLEKN EEEECCCCCCCCCCC | 17.23 | 25159151 | |
| 330 | Ubiquitination | MSPGNLEKNRYGDVP CCCCCCCCCCCCCCC | 50.30 | - | |
| 333 | Phosphorylation | GNLEKNRYGDVPCLD CCCCCCCCCCCCCCC | 27.37 | 29052541 | |
| 342 | Phosphorylation | DVPCLDQTRVKLTKR CCCCCCCCEEEEEEC | 36.78 | 29052541 | |
| 357 | Phosphorylation | SGHTQTDYINASFMD CCCCCCCCEEHHHCC | 10.24 | 28796482 | |
| 367 | Ubiquitination | ASFMDGYKQKNAYIG HHHCCCCCCCCCCCC | 61.39 | - | |
| 372 | Phosphorylation | GYKQKNAYIGTQGPL CCCCCCCCCCCCCCC | 14.85 | 21406692 | |
| 375 | Phosphorylation | QKNAYIGTQGPLENT CCCCCCCCCCCCCCC | 22.31 | 20068231 | |
| 382 | Phosphorylation | TQGPLENTYRDFWLM CCCCCCCCCHHHHHH | 15.57 | 21406692 | |
| 383 | Phosphorylation | QGPLENTYRDFWLMV CCCCCCCCHHHHHHH | 21.55 | 21406692 | |
| 442 | Phosphorylation | GVENMNHYKKTTLEI CCCCCCCCCCCEEEE | 14.80 | - | |
| 444 | Ubiquitination | ENMNHYKKTTLEIHN CCCCCCCCCEEEECC | 39.31 | - | |
| 498 | Sulfoxidation | QSLAVSNMGARSKGQ CCHHHCCCCCCCCCC | 3.28 | 21406390 | |
| 503 | Ubiquitination | SNMGARSKGQCPEPP CCCCCCCCCCCCCCC | 47.66 | - | |
| 557 | Phosphorylation | MRTQRAFSIQTPEQY HHCCCCCCCCCHHHH | 16.89 | 26552605 | |
| 560 | Phosphorylation | QRAFSIQTPEQYYFC CCCCCCCCHHHHHHH | 27.42 | 27251275 | |
| 564 | Phosphorylation | SIQTPEQYYFCYKAI CCCCHHHHHHHHHHH | 9.24 | 27251275 | |
| 565 | Phosphorylation | IQTPEQYYFCYKAIL CCCHHHHHHHHHHHH | 6.20 | 26552605 | |
| 568 | Phosphorylation | PEQYYFCYKAILEFA HHHHHHHHHHHHHHH | 8.11 | 27251275 | |
| 592 | Phosphorylation | QNLLAVESQ------ CCEEEEECC------ | 34.29 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PTN9_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTN9_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTN9_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RTN3_HUMAN | RTN3 | physical | 16189514 | |
| RTN3_HUMAN | RTN3 | physical | 25416956 | |
| ATRAP_HUMAN | AGTRAP | physical | 25416956 | |
| REEP6_HUMAN | REEP6 | physical | 25416956 | |
| MAL2_HUMAN | MAL2 | physical | 25416956 | |
| CKLF5_HUMAN | CMTM5 | physical | 25416956 | |
| LZTR1_HUMAN | LZTR1 | physical | 27880917 | |
| PYC_HUMAN | PC | physical | 27880917 | |
| FA26D_HUMAN | FAM26D | physical | 28514442 | |
| LZTR1_HUMAN | LZTR1 | physical | 27432908 | |
| PTN9_HUMAN | PTPN9 | physical | 27432908 | |
| GEMI8_HUMAN | GEMIN8 | physical | 27432908 | |
| FSIP1_HUMAN | FSIP1 | physical | 27432908 | |
| SMN_HUMAN | SMN1 | physical | 27432908 | |
| DDX20_HUMAN | DDX20 | physical | 27432908 | |
| GEMI4_HUMAN | GEMIN4 | physical | 27432908 | |
| MPPA_HUMAN | PMPCA | physical | 27432908 | |
| S39A7_HUMAN | SLC39A7 | physical | 27432908 | |
| STRAP_HUMAN | STRAP | physical | 27432908 | |
| TBA3C_HUMAN | TUBA3C | physical | 27432908 | |
| AAR2_HUMAN | AAR2 | physical | 27432908 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |